Phase Ib Study of Enzalutamide with or Without Sorafenib in Patients with Advanced Hepatocellular Carcinoma.
Saved in:
| Title: | Phase Ib Study of Enzalutamide with or Without Sorafenib in Patients with Advanced Hepatocellular Carcinoma. |
|---|---|
| Authors: | Harding JJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York, USA., Kelley RK; Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA., Tan B; Department of Medicine, Washington University, St. Louis, Missouri, USA., Capanu M; Department of Epidemiology-Biostatistics, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York, USA., Do GK; Department of Radiology, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York, USA., Shia J; Department of Pathology, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York, USA., Chou JF; Department of Epidemiology-Biostatistics, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York, USA., Ferrer CS; Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York, USA., Boussayoud C; Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York, USA., Muenkel K; Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York, USA., Yarmohammadi H; Department of Radiology, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York, USA., El Dika I; Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York, USA., Khalil DN; Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York, USA., Ruiz C; University of Southern California USC Michelson Center, Los Angeles, California, USA., Rodriguez-Lee M; University of Southern California USC Michelson Center, Los Angeles, California, USA., Kuhn P; University of Southern California USC Michelson Center, Los Angeles, California, USA., Wilton J; Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York, USA., Iyer R; Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York, USA., Abou-Alfa GK; Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York, USA. |
| Source: | The oncologist [Oncologist] 2020 Dec; Vol. 25 (12), pp. e1825-e1836. Date of Electronic Publication: 2020 Jul 02. |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 32548867 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Phase Ib Study of Enzalutamide with or Without Sorafenib in Patients with Advanced Hepatocellular Carcinoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Harding+JJ%22">Harding JJ</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Kelley+RK%22">Kelley RK</searchLink>; Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Tan+B%22">Tan B</searchLink>; Department of Medicine, Washington University, St. Louis, Missouri, USA.<br /><searchLink fieldCode="AU" term="%22Capanu+M%22">Capanu M</searchLink>; Department of Epidemiology-Biostatistics, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Do+GK%22">Do GK</searchLink>; Department of Radiology, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Shia+J%22">Shia J</searchLink>; Department of Pathology, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Chou+JF%22">Chou JF</searchLink>; Department of Epidemiology-Biostatistics, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Ferrer+CS%22">Ferrer CS</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Boussayoud+C%22">Boussayoud C</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Muenkel+K%22">Muenkel K</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Yarmohammadi+H%22">Yarmohammadi H</searchLink>; Department of Radiology, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22El+Dika+I%22">El Dika I</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Khalil+DN%22">Khalil DN</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Ruiz+C%22">Ruiz C</searchLink>; University of Southern California USC Michelson Center, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Rodriguez-Lee+M%22">Rodriguez-Lee M</searchLink>; University of Southern California USC Michelson Center, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Kuhn+P%22">Kuhn P</searchLink>; University of Southern California USC Michelson Center, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Wilton+J%22">Wilton J</searchLink>; Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York, USA.<br /><searchLink fieldCode="AU" term="%22Iyer+R%22">Iyer R</searchLink>; Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York, USA.<br /><searchLink fieldCode="AU" term="%22Abou-Alfa+GK%22">Abou-Alfa GK</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229607837%22">The oncologist</searchLink> [Oncologist] 2020 Dec; Vol. 25 (12), pp. e1825-e1836. <i>Date of Electronic Publication: </i>2020 Jul 02. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9607837 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1549-490X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210837159%22">10837159 </searchLink><i>NLM ISO Abbreviation: </i>Oncologist <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32548867 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1634/theoncologist.2020-0521 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e1825 Titles: – TitleFull: Phase Ib Study of Enzalutamide with or Without Sorafenib in Patients with Advanced Hepatocellular Carcinoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Harding JJ – PersonEntity: Name: NameFull: Kelley RK – PersonEntity: Name: NameFull: Tan B – PersonEntity: Name: NameFull: Capanu M – PersonEntity: Name: NameFull: Do GK – PersonEntity: Name: NameFull: Shia J – PersonEntity: Name: NameFull: Chou JF – PersonEntity: Name: NameFull: Ferrer CS – PersonEntity: Name: NameFull: Boussayoud C – PersonEntity: Name: NameFull: Muenkel K – PersonEntity: Name: NameFull: Yarmohammadi H – PersonEntity: Name: NameFull: El Dika I – PersonEntity: Name: NameFull: Khalil DN – PersonEntity: Name: NameFull: Ruiz C – PersonEntity: Name: NameFull: Rodriguez-Lee M – PersonEntity: Name: NameFull: Kuhn P – PersonEntity: Name: NameFull: Wilton J – PersonEntity: Name: NameFull: Iyer R – PersonEntity: Name: NameFull: Abou-Alfa GK IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2020 Dec Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 1549-490X Numbering: – Type: volume Value: 25 – Type: issue Value: 12 Titles: – TitleFull: The oncologist Type: main |
| ResultId | 1 |